AbbVie Inc (ABBV)
$216.31-1.06%
Spriggl Score: Moderate— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Dividend compounder beating and raising every quarter; Skyrizi +30.9% with patent runway to 2033. Reasonable 14x forward P/E and 3.3% yield — debt load the only structural concern.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About AbbVie Inc
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvi…
- Sector:
- Healthcare
- Industry:
- Drug Manufacturers - General
- Market Cap:
- $372.4B
Recent dividends
- 15 Apr 2026$1.73
- 16 Jan 2026$1.73
- 15 Oct 2025$1.64
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on AbbVie Inc and 1,600+ UK and US stocks.
Start free